오성용 교수 연구실
article|
인용수 3
·2023
1885P Pexa-vec (thymidine kinase-deactivated vaccinia virus plus GM-CSF) in combination with cemiplimab (REGN2810; ANTI-PD-1) for metastatic or unresectable renal cell carcinoma REN026: Results from a phase II study
Sun Young Rha, Woo Kyun Bae, Chung Hun Kim, Sung Yong Oh, Hyun Woo Lee, K. Park, Nataliya Mar, Ganessan Kichenadasse, Hong Koo Ha, Russell K. Pachynski, Inkeun Park, K.H. Park, Sihyun Kim, Edmund Folefac, Melissa Mathias, Frank Seebach, Mohammad Ali Shokrgozar, Lorena Carranza, S-H. Beom, Jaime R. Merchan
IF 56.7Annals of Oncology
키워드
MedicineRenal cell carcinomaVacciniaInternal medicineGastroenterology